Analyze Diet
Journal of immunology research2026; 2026(1); e5310284; doi: 10.1155/jimr/5310284

Circulating Cell-Free RNA Reflects Immune-Associated and Airway Remodeling Signatures in Equine Asthma.

Abstract: Circulating cell-free RNA (cfRNA) has emerged as a promising minimally invasive biomarker capable of capturing transcripts originating from multiple tissues and cell types, but its utility in chronic inflammatory airway diseases remains poorly understood. Equine asthma (EA), a naturally occurring respiratory disease that shares key clinical and immunopathological features with human asthma, provides a valuable comparative model for evaluating plasma cfRNA in this context. We performed transcriptomic profiling of plasma cfRNA from horses with EA and healthy controls and compared these findings with partially matched bronchoalveolar lavage (BAL) and whole-blood (WB) transcriptomes. Differential abundance analysis of plasma cfRNA identified increased abundance of the epithelial alarmin IL33, together with signatures associated with tissue remodeling, cellular stress responses, and immune alterations. Notably, cfRNA from EA horses exhibited reduced B-cell-associated and increased T-cell-associated transcript signatures, a pattern independently supported by differential abundance, co-expression network, and deconvolution analyses. In contrast, similar immune-associated signatures were not evident in the BAL and WB transcriptomes analyzed in this study. Cross-compartment comparisons further demonstrated that plasma cfRNA captured a molecular profile largely distinct from those identified in BAL and WB, while sharing only a small set of differentially abundant transcripts across compartments. Collectively, these findings indicate that plasma cfRNA captures molecular patterns associated with EA that differ from those observed in conventional transcriptomic sampling compartments. These results support the potential utility of plasma cfRNA as a minimally invasive source of biomarkers for characterizing airway disease-associated molecular and immune alterations in both veterinary and comparative asthma research.
Publication Date: 2026-08-26 PubMed ID: 42644703PubMed Central: PMC13509420DOI: 10.1155/jimr/5310284Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates how circulating cell-free RNA (cfRNA) in the blood plasma can reflect immune system changes and airway tissue remodeling in equine asthma, a horse respiratory disease similar to human asthma.
  • The research demonstrates that cfRNA profiles differ from those obtained through traditional sampling methods (bronchoalveolar lavage and whole blood), highlighting cfRNA as a novel, minimally invasive biomarker for airway disease.

Background and Rationale

  • Circulating cell-free RNA (cfRNA) refers to fragments of RNA freely circulating in the bloodstream, originating from various tissues and cells.
  • CfRNA is gaining interest as a minimally invasive biomarker because it can provide molecular insights without needing direct tissue sampling.
  • Chronic inflammatory airway diseases like asthma involve complex interactions of immune responses and tissue remodeling but the role of cfRNA in such diseases is not well established.
  • Equine asthma (EA) is a naturally occurring respiratory disease in horses sharing clinical and biological similarities with human asthma, making it an excellent comparative model.

Study Objective

  • To profile plasma cfRNA in horses with EA and compare it to healthy controls.
  • To compare cfRNA findings with transcriptomes from bronchoalveolar lavage (BAL) fluid and whole blood (WB) to understand how cfRNA signatures reflect airway disease.

Methodology

  • Plasma samples were collected from horses diagnosed with EA and from healthy controls.
  • Transcriptomic profiling of circulating cfRNA was performed to identify differences in RNA abundance between groups.
  • Transcriptomes from partially matched BAL fluid and whole blood samples were also analyzed to compare molecular signatures across compartments.
  • Analytical approaches included differential abundance analysis, co-expression network analysis, and immune cell deconvolution techniques.

Key Findings

  • Plasma cfRNA from EA horses showed elevated levels of IL33, an epithelial alarmin known to be involved in airway inflammation and remodeling.
  • Additional signatures related to tissue remodeling, cellular stress, and immune alterations were also identified in cfRNA profiles.
  • Immune cell signature shifts were observed in cfRNA: a decrease in B-cell-related transcripts and an increase in T-cell-related transcripts, indicating immune dysregulation.
  • These immune signature changes in cfRNA were supported by multiple independent analyses (differential abundance, network, deconvolution).
  • By contrast, immune-associated transcript changes seen in plasma cfRNA were not evident in either BAL or WB transcriptomes in this study.
  • Cross-comparisons showed that plasma cfRNA profiles largely represented molecular information distinct from BAL and WB, with only a small overlap in differentially abundant transcripts.

Interpretation and Implications

  • The study indicates that plasma cfRNA can reveal unique molecular patterns associated with EA that are not captured by conventional transcriptomic methods applied to airway fluid or blood cells.
  • Circulating cfRNA may provide information about both immune system changes and airway tissue remodeling in asthma without invasive sampling.
  • This suggests potential for cfRNA as a convenient, minimally invasive biomarker source to monitor airway disease severity, progression, or treatment response in veterinary medicine.
  • Due to the similarities between equine and human asthma, findings may inform biomarker development and disease understanding in human asthma research as well.

Conclusions

  • Plasma cfRNA is an informative biomarker reflecting immune and airway remodeling signatures in equine asthma.
  • CfRNA molecular profiles differ from those found in traditional compartments (BAL and whole blood), highlighting its complementary role.
  • These findings support further exploration of plasma cfRNA as a minimally invasive tool for studying and managing airway inflammatory diseases in both horses and possibly humans.

Cite This Article

APA
Zhang B, Agdour H, Riihimäki M, Hansen S, Raine A. (2026). Circulating Cell-Free RNA Reflects Immune-Associated and Airway Remodeling Signatures in Equine Asthma. J Immunol Res, 2026(1), e5310284. https://doi.org/10.1155/jimr/5310284

Publication

ISSN: 2314-7156
NlmUniqueID: 101627166
Country: Egypt
Language: English
Volume: 2026
Issue: 1
Pages: e5310284
PII: 5310284

Researcher Affiliations

Zhang, Birong
  • Department of Medical Sciences, Uppsala University, Uppsala, Sweden, uu.se.
  • Science for Life Laboratory, Uppsala, Sweden, scilifelab.se.
Agdour, Hanna
  • Department of Medical Sciences, Uppsala University, Uppsala, Sweden, uu.se.
  • Science for Life Laboratory, Uppsala, Sweden, scilifelab.se.
Riihimäki, Miia
  • Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden, slu.se.
Hansen, Sanni
  • Department of Veterinary Clinical Sciences, University of Copenhagen, Copenhagen, Denmark, ku.dk.
Raine, Amanda
  • Department of Medical Sciences, Uppsala University, Uppsala, Sweden, uu.se.
  • Science for Life Laboratory, Uppsala, Sweden, scilifelab.se.

MeSH Terms

  • Animals
  • Horses
  • Asthma / immunology
  • Asthma / veterinary
  • Asthma / blood
  • Asthma / diagnosis
  • Asthma / genetics
  • Biomarkers / blood
  • Airway Remodeling / immunology
  • Airway Remodeling / genetics
  • Cell-Free Nucleic Acids / blood
  • Cell-Free Nucleic Acids / genetics
  • Horse Diseases / immunology
  • Horse Diseases / blood
  • Horse Diseases / diagnosis
  • Horse Diseases / genetics
  • Gene Expression Profiling
  • Transcriptome
  • Bronchoalveolar Lavage Fluid / immunology

Grant Funding

  • H-22-47-717 / Swedish-Norwegian Foundation for Equine Research
  • 2023-01377 / FORMAS
  • Uppsala Universitet

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 50 references
  1. Bigler J, Boedigheimer M, Schofield JPR. A Severe Asthma Disease Signature From Gene Expression Profiling of Peripheral Blood From U-BIOPRED Cohorts. American Journal of Respiratory and Critical Care Medicine 2017 195, no. 10, 1311–1320.
    doi: 10.1164/rccm.201604-0866OCpubmed: 27925796google scholar: lookup
  2. Couetil L, Cardwell JM, Leguillette R. Equine Asthma: Current Understanding and Future Directions. Frontiers in Veterinary Science 2020 7, 450.
    doi: 10.3389/fvets.2020.00450pmc: PMC7438831pubmed: 32903600google scholar: lookup
  3. Couëtil LL, Cardwell JM, Gerber V, Lavoie J-P, Léguillette R, Richard EA. Inflammatory Airway Disease of Horses—Revised Consensus Statement. Journal of Veterinary Internal Medicine 2016 30, no. 2, 503–515.
    doi: 10.1111/jvim.13824pmc: PMC4913592pubmed: 26806374google scholar: lookup
  4. Herszberg B, Ramos-Barbón D, Tamaoka M, Martin JG, Lavoie J-P. Heaves, An Asthma-Like Equine Disease, Involves Airway Smooth Muscle Remodeling. Journal of Allergy and Clinical Immunology 2006 118, no. 2, 382–388.
    doi: 10.1016/j.jaci.2006.03.044pubmed: 16890762google scholar: lookup
  5. Millares-Ramirez EM, Dupuis-Dowd F, Mainguy-Seers S, Lavoie J-P. Bronchial Vessel Density is Correlated With Airway Smooth Muscle Cell Proliferation in Horses With Mild and Moderate Asthma. American Journal of Veterinary Research 2025 86, no. 3, ajvr.24.10.0318.
    doi: 10.2460/ajvr.24.10.0318pubmed: 39787707google scholar: lookup
  6. Dupuis-Dowd F, Lavoie J-P. Airway Smooth Muscle Remodelling in Mild and Moderate Equine Asthma. Equine Veterinary Journal 2022 54, no. 5, 865–874.
    doi: 10.1111/evj.13514pubmed: 34529300google scholar: lookup
  7. Carter SWD, Seah KYM, Poh SE. Maternal Plasma Cell-Free RNA as a Predictive Test for Fetal Lung Maturation. BMC Medicine 2025 23, no. 1, 441.
    doi: 10.1186/s12916-025-04256-ypmc: PMC12305955pubmed: 40722151google scholar: lookup
  8. Larson MH, Pan W, Kim HJ. A Comprehensive Characterization of the Cell-Free Transcriptome Reveals Tissue- and Subtype-Specific Biomarkers for Cancer Detection. Nature Communications 2021 12, no. 1, 2357.
    doi: 10.1038/s41467-021-22444-1pmc: PMC8060291pubmed: 33883548google scholar: lookup
  9. Chaddha M, Rai H, Gupta R, Thakral D. Integrated Analysis of Circulating Cell Free Nucleic Acids for Cancer Genotyping and Immune Phenotyping of Tumor Microenvironment. Frontiers in Genetics 2023 14, 1138625.
    doi: 10.3389/fgene.2023.1138625pmc: PMC10117686pubmed: 37091783google scholar: lookup
  10. Murillo OD, Thistlethwaite W, Rozowsky J. exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present Across Human Biofluids. Cell 2019 177, no. 2, 463–477.e15.
    doi: 10.1016/j.cell.2019.02.018pmc: PMC6616370pubmed: 30951672google scholar: lookup
  11. Alashkar Alhamwe B, Potaczek DP, Miethe S. Extracellular Vesicles and Asthma—More Than Just a Co-Existence. International Journal of Molecular Sciences 2021 22, no. 9, 4984.
    doi: 10.3390/ijms22094984pmc: PMC8124625pubmed: 34067156google scholar: lookup
  12. Miethe S, Potaczek DP, Bazan-Socha S. The Emerging Role of Extracellular Vesicles as Communicators Between Adipose Tissue and Pathologic Lungs With a Special Focus on Asthma. American Journal of Physiology-Cell Physiology 2023 324, no. 5, C1119–C1125.
    doi: 10.1152/ajpcell.00057.2023pubmed: 37067460google scholar: lookup
  13. Alhamdan F, Greulich T, Daviaud C. Identification of Extracellular Vesicle microRNA Signatures Specifically Linked to Inflammatory and Metabolic Mechanisms in Obesity-Associated Low Type-2 Asthma. Allergy 2023 78, no. 11, 2944–2958.
    doi: 10.1111/all.15824pubmed: 37486026google scholar: lookup
  14. Browne W, Hopkins G, Cochrane S, James V, Onion D, Fairclough LC. The Role of Epithelial-Derived Extracellular Vesicles in Allergic Sensitisation: A Systematic Review. International Journal of Molecular Sciences 2025 26, no. 12, 5791.
    doi: 10.3390/ijms26125791pmc: PMC12193434pubmed: 40565252google scholar: lookup
  15. De Sota RE, Quake SR, Sninsky JJ, Toden S. Decoding Bioactive Signals of the RNA Secretome: The Cell-Free Messenger RNA Catalogue. Expert Reviews in Molecular Medicine 2024 26, e12.
    doi: 10.1017/erm.2024.12pmc: PMC11140549pubmed: 38682644google scholar: lookup
  16. Ibarra A, Zhuang J, Zhao Y. Non-Invasive Characterization of Human Bone Marrow Stimulation and Reconstitution by Cell-Free Messenger RNA Sequencing. Nature Communications (2020) 11, no. 1, 400.
    doi: 10.1038/s41467-019-14253-4pmc: PMC6972916pubmed: 31964864google scholar: lookup
  17. Koh W, Pan W, Gawad C. Noninvasive In Vivo Monitoring of Tissue-Specific Global Gene Expression in Humans. Proceedings of the National Academy of Sciences (2014) 111, no. 20, 7361–7366.
    doi: 10.1073/pnas.1405528111pmc: PMC4034220pubmed: 24799715google scholar: lookup
  18. Zhong P, Bai L, Hong M. A Comprehensive Review on Circulating cfRNA in Plasma: Implications for Disease Diagnosis and Beyond. Diagnostics (2024) 14, no. 10, 1045.
  19. Riihimäki M, Fegraeus K, Nordlund J. Single-Cell Transcriptomics Delineates the Immune Cell Landscape in Equine Lower Airways and Reveals Upregulation of FKBP5 in Horses With Asthma. Scientific Reports (2023) 13, no. 1, 16261.
    doi: 10.1038/s41598-023-43368-4pmc: PMC10533524pubmed: 37758813google scholar: lookup
  20. Love M I, Huber W, Anders S. Moderated Estimation of Fold Change and Dispersion for RNA-seq Data With DESeq2. Genome Biology (2014) 15, no. 12, 550.
    doi: 10.1186/s13059-014-0550-8pmc: PMC4302049pubmed: 25516281google scholar: lookup
  21. Wu T, Hu E, Xu S. clusterProfiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data. Innovation (2021) 2, no. 3, 100141.
    pmc: PMC8454663pubmed: 34557778
  22. Smedley D, Haider S, Ballester B. BioMart—Biological Queries Made Easy. BMC Genomics (2009) 10, no. 1, 22.
    doi: 10.1186/1471-2164-10-22pmc: PMC2649164pubmed: 19144180google scholar: lookup
  23. Vorperian S K, Moufarrej M N, Consortium T S, Quake S R. Cell Types of Origin of the Cell-Free Transcriptome. Nature Biotechnology (2022) 40, no. 6, 855–861.
    doi: 10.1038/s41587-021-01188-9pmc: PMC9200634pubmed: 35132263google scholar: lookup
  24. Chen B, Khodadoust M S, Liu C L, Newman A M, Alizadeh A A. Profiling Tumor Infiltrating Immune Cells With CIBERSORT. Methods in Molecular Biology (2018) 1711, 243–259.
    doi: 10.1007/978-1-4939-7493-1pmc: PMC5895181pubmed: 29344893google scholar: lookup
  25. Hunt G J, Freytag S, Bahlo M, Gagnon-Bartsch J A, Kelso J. dtangle: Accurate and Robust Cell Type Deconvolution. Bioinformatics (2019) 35, no. 12, 2093–2099.
    doi: 10.1093/bioinformatics/bty926pubmed: 30407492google scholar: lookup
  26. Aran D, Hu Z, Butte A J. xCell: Digitally Portraying the Tissue Cellular Heterogeneity Landscape. Genome Biology (2017) 18, no. 1, 220.
    doi: 10.1186/s13059-017-1349-1pmc: PMC5688663pubmed: 29141660google scholar: lookup
  27. Patel R S, Tomlinson J E, Divers T J, Van de Walle G R, Rosenberg B R. Single-Cell Resolution Landscape of Equine Peripheral Blood Mononuclear Cells Reveals Diverse Cell Types including T-Bet+ B Cells. BMC Biology (2021) 19, no. 1, 13.
    doi: 10.1186/s12915-020-00947-5pmc: PMC7820527pubmed: 33482825google scholar: lookup
  28. Langfelder P, Horvath S. WGCNA: An R Package for Weighted Correlation Network Analysis. BMC Bioinformatics (2008) 9, no. 1, 559.
    doi: 10.1186/1471-2105-9-559pmc: PMC2631488pubmed: 19114008google scholar: lookup
  29. Cayrol C, Girard J-P. Interleukin-33 (IL-33): A Critical Review of Its Biology and the Mechanisms Involved in Its Release as a Potent Extracellular Cytokine. Cytokine (2022) 156, 155891.
    doi: 10.1016/j.cyto.2022.155891pubmed: 35640416google scholar: lookup
  30. Lima L C, de Queiroz G A, Costa R D S. Genetic Variants in RORA Are Associated With Asthma and Allergy Markers in an Admixed Population. Cytokine (2019) 113, 177–184.
    doi: 10.1016/j.cyto.2018.07.004pubmed: 30539779google scholar: lookup
  31. Rothenberg M. E., Wen T., Shik D., Cole E. T., Mingler M. M., Munitz A.. IL-13 Receptor α1 Differentially Regulates Aeroallergen-Induced Lung Responses. The Journal of Immunology (2011) 187, no. 9, 4873–4880.
    doi: 10.4049/jimmunol.1004159pmc: PMC3197875pubmed: 21957151google scholar: lookup
  32. Cataldo D. D., Gueders M., Munaut C.. Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases mRNA Transcripts in the Bronchial Secretions of Asthmatics. Laboratory Investigation (2004) 84, no. 4, 418–424.
    doi: 10.1038/labinvest.3700063pubmed: 14968124google scholar: lookup
  33. Hough K. P., Curtiss M. L., Blain T. J.. Airway Remodeling in Asthma. Frontiers in Medicine (2020) 7, 191.
    doi: 10.3389/fmed.2020.00191pmc: PMC7253669pubmed: 32509793google scholar: lookup
  34. Ma Z., Paek D., Oh C. K.. Plasminogen Activator Inhibitor-1 and Asthma: Role in the Pathogenesis and Molecular Regulation. Clinical & Experimental Allergy (2009) 39, no. 8, 1136–1144.
  35. Paulissen G., Rocks N., Gueders M. M.. Role of ADAM and ADAMTS Metalloproteinases in Airway Diseases. Respiratory Research (2009) 10, no. 1, 127.
    doi: 10.1186/1465-9921-10-127pmc: PMC2805617pubmed: 20034386google scholar: lookup
  36. Morris A., Wang B., Waern I.. The Role of Heparanase in Pulmonary Cell Recruitment in Response to an Allergic but Not Non-Allergic Stimulus. PLoS ONE (2015) 10, no. 6, e0127032.
  37. Ma L., Brown M., Kogut P.. Akt Activation Induces Hypertrophy Without Contractile Phenotypic Maturation in Airway Smooth Muscle. American Journal of Physiology-Lung Cellular and Molecular Physiology (2011) 300, no. 5, L701–L709.
    doi: 10.1152/ajplung.00119.2009pmc: PMC3094029pubmed: 21378028google scholar: lookup
  38. Yue M., Hu M., Fu F., Ruan H., Wu C.. Emerging Roles of Platelets in Allergic Asthma. Frontiers in Immunology (2022) 13, 846055.
    doi: 10.3389/fimmu.2022.846055pmc: PMC9010873pubmed: 35432313google scholar: lookup
  39. Heryanto Y. D., Imoto S.. Identifying Key Regulators of Keratinization in Lung Squamous Cell Cancer Using Integrated TCGA Analysis. Cancers (2023) 15, no. 7, 2066.
    doi: 10.3390/cancers15072066pmc: PMC10092975pubmed: 37046726google scholar: lookup
  40. Pieper K., Grimbacher B., Eibel H.. B-Cell Biology and Development. Journal of Allergy and Clinical Immunology (2013) 131, no. 4, 959–971.
    doi: 10.1016/j.jaci.2013.01.046pubmed: 23465663google scholar: lookup
  41. Roche P. A., Furuta K.. The Ins and Outs of MHC Class II-Mediated Antigen Processing and Presentation. Nature Reviews Immunology (2015) 15, no. 4, 203–216.
    doi: 10.1038/nri3818pmc: PMC6314495pubmed: 25720354google scholar: lookup
  42. Chiduza G. N., Garza-Garcia A., Almacellas E.. ATG9B is a Tissue-Specific Homotrimeric Lipid Scramblase That Can Compensate for ATG9A. Autophagy (2024) 20, no. 3, 557–576.
  43. Dong H., Yang W., Li W.. New Insights Into Autophagy in Inflammatory Subtypes of Asthma. Frontiers in Immunology (2023) 14, 1156086.
    doi: 10.3389/fimmu.2023.1156086pmc: PMC10117973pubmed: 37090692google scholar: lookup
  44. Gressler A. E., Lübke S., Wagner B., Arnold C., Lohmann K. L., Schnabel C. L.. Comprehensive Flow Cytometric Characterization of Bronchoalveolar Lavage Cells Indicates Comparable Phenotypes Between Asthmatic and Healthy Horses but Functional Lymphocyte Differences. Frontiers in Immunology (2022) 13, 896255.
    doi: 10.3389/fimmu.2022.896255pmc: PMC9296846pubmed: 35874777google scholar: lookup
  45. Loy C. J., Servellita V., Sotomayor-Gonzalez A.. Plasma Cell-Free RNA Signatures of Inflammatory Syndromes in Children. Proceedings of the National Academy of Sciences (2024) 121, no. 37, e2403897121.
    doi: 10.1073/pnas.2403897121pmc: PMC11406294pubmed: 39240972google scholar: lookup
  46. Chang J, Xia Y-F, Zhang M-Z, Zhang L-M. IL-33 Signaling in Lung Injury. Translational Perioperative and Pain Medicine (2016) 1, no. 2, 24–32.
    pmc: PMC4985245pubmed: 27536706
  47. Rajput C, Cui T, Han M. RORα-Dependent Type 2 Innate Lymphoid Cells Are Required and Sufficient for Mucous Metaplasia in Immature Mice. American Journal of Physiology-Lung Cellular and Molecular Physiology (2017) 312, no. 6, L983–L993.
    doi: 10.1152/ajplung.00368.2016pmc: PMC5495952pubmed: 28360114google scholar: lookup
  48. Zhang D, Liu W, Wang T. Asthmatic Pulmonary Fibroblasts Aggravate Airway Inflammation Through FKBP5-Dependent Necroptosis. American Journal of Respiratory Cell and Molecular Biology (2026) 15, aanag080.
    doi: 10.1093/ajrcmb/aanag080pubmed: 42089322google scholar: lookup
  49. Sender R, Weiss Y, Navon Y. The Total Mass, Number, and Distribution of Immune Cells in the Human Body. Proceedings of the National Academy of Sciences (2023) 120, no. 44, e2308511120.
    doi: 10.1073/pnas.2308511120pmc: PMC10623016pubmed: 37871201google scholar: lookup
  50. Zhang B, Agdour H, Riihimäki M, Hansen S, Raine A. Circulating Cell-Free RNA Reflects Inflammatory and Airway Remodeling Signatures in an Equine Model of Asthma. Genomics (2025).
    pmc: PMC13509420pubmed: 42644703

Citations

This article has been cited 0 times.